Chronic respiratory diseases, which are still incurable and need novel therapeutic tools, are characterized by unsurmountable oxidative stress. Grape phenolic compounds, such as proanthocyanidins, are endowed with well-recognized anti-oxidant and anti-inflammatory activities. Given that these natural anti-oxidants have poor water solubility and oral bioavailability, we have developed a drug delivery system based on solid lipid nanoparticles (SLN), in order to encapsulate these therapeutic molecules. Since we previously demonstrated the safety and the internalization efficiency of SLN in airway epithelial cells in vitro (Castellani et al., submitted), our aim was to test their efficacy in reducing oxidative stress when used as carriers for molecules derived from grape seed extracts (GSE).
Solid lipid nanoparticles-mediated delivery of grape seed-derived proanthocyanidins to airway epithelial cells reduce oxidative stress
Stefano Castellani;Adriana Trapani;Anna Spagnoletta;Lorena di Toma;Delia Mandracchia;Thea Magrone;Giuseppe Trapani;Emilio Jirillo;
2018-01-01
Abstract
Chronic respiratory diseases, which are still incurable and need novel therapeutic tools, are characterized by unsurmountable oxidative stress. Grape phenolic compounds, such as proanthocyanidins, are endowed with well-recognized anti-oxidant and anti-inflammatory activities. Given that these natural anti-oxidants have poor water solubility and oral bioavailability, we have developed a drug delivery system based on solid lipid nanoparticles (SLN), in order to encapsulate these therapeutic molecules. Since we previously demonstrated the safety and the internalization efficiency of SLN in airway epithelial cells in vitro (Castellani et al., submitted), our aim was to test their efficacy in reducing oxidative stress when used as carriers for molecules derived from grape seed extracts (GSE).File | Dimensione | Formato | |
---|---|---|---|
Abstract-Book_Nanomedicine-Roma-2018 .pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
5.5 MB
Formato
Adobe PDF
|
5.5 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.